Title: Targeting the tumor microenvironment: focus on angiogenesis.
Journal: Journal of oncology 20120101
Title: [The Neurosedyn disaster became a starting shot. The drug approval process was changed and new era of patient safety was initiated].
Journal: Lakartidningen 20111101
Title: Isomin: a novel cytoplasmic intermediate filament protein from an arthropod species.
Journal: BMC biology 20110101
Title: History and phylogeny of intermediate filaments: now in insects.
Journal: BMC biology 20110101
Title: Epidemiological surveillance of birth defects compatible with thalidomide embryopathy in Brazil.
Journal: PloS one 20110101
Title: Radiotherapy and 'new' drugs-new side effects?
Journal: Radiation oncology (London, England) 20110101
Title: Evaluating the efficacy of tryptophan fluorescence and absorbance as a selection tool for identifying protein crystals.
Journal: Acta crystallographica. Section F, Structural biology and crystallization communications 20100301
Title: Angiogenesis inhibition in prostate cancer: current uses and future promises.
Journal: Journal of oncology 20100101
Title: The legal standards for the radioactive or non radioactive drugs research and approval in the European Community and in Germany after the thalidomide catastrophe.
Journal: Hellenic journal of nuclear medicine 20100101
Title: Anti-angiogenesis therapies: their potential in cancer management.
Journal: OncoTargets and therapy 20100101
Title: Progranulin modulates zebrafish motoneuron development in vivo and rescues truncation defects associated with knockdown of Survival motor neuron 1.
Journal: Molecular neurodegeneration 20100101
Title: Synthesis, configurational stability and stereochemical biological evaluations of (S)- and (R)-5-hydroxythalidomides.
Journal: Bioorganic & medicinal chemistry letters 20090715
Title: Comparison between measurements obtained with three different perineometers.
Journal: Clinics (Sao Paulo, Brazil) 20090601
Title: Effects of inducible nitric oxide synthase inhibition or norepinephrine on the neurovascular coupling in an endotoxic rat shock model.
Journal: Critical care (London, England) 20090101
Title: Progranulin is expressed within motor neurons and promotes neuronal cell survival.
Journal: BMC neuroscience 20090101
Title: [Contergan writes its history (interview by Angelika Staub)].
Journal: Kinderkrankenschwester : Organ der Sektion Kinderkrankenpflege 20071201
Title: Evaluation of chemical and photochemical oxidation processes for degradation of phosmet on lowbush blueberries (Vaccinium angustifolium).
Journal: Journal of agricultural and food chemistry 20061213
Title: Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods.
Journal: Journal of molecular graphics & modelling 20061101
Title: Organophosphate pesticide exposure and neurobehavioral performance in agricultural and non-agricultural Hispanic workers.
Journal: Environmental health perspectives 20060501
Title: Comparative effectiveness of different insecticides for organic management of blueberry maggot (Diptera: Tephritidae).
Journal: Journal of economic entomology 20050801
Title: Variation in organophosphate pesticide metabolites in urine of children living in agricultural communities.
Journal: Environmental health perspectives 20050401
Title: Teratology in cultural documents and today.
Journal: Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft 20041201
Title: Mechanisms of action and potential therapeutic uses of thalidomide.
Journal: Croatian medical journal 20020601
Title: [On the history of the Contergan (thalidomide) catastrophe in the light of drug legislation].
Journal: Deutsche medizinische Wochenschrift (1946) 20011019
Title: Structure-activity relationships for a large diverse set of natural, synthetic, and environmental estrogens.
Journal: Chemical research in toxicology 20010301
Title: Thalomid (Thalidomide) capsules: a review of the first 18 months of spontaneous postmarketing adverse event surveillance, including off-label prescribing.
Journal: Drug safety 20010101
Title: Thalidomide as an anti-angiogenic agent in relapsed gliomas.
Journal: Journal of neuro-oncology 20010101
Title: Murphy S, et al. Enantioselectivity of thalidomide serum and tissue concentrations in a rat glioma model and effects of combination treatment with cisplatin and BCNU. J Pharm Pharmacol. 2007 Jan;59(1):105-14.
Title: Eriksson T, et al. Intravenous formulations of the enantiomers of thalidomide: pharmacokinetic and initial pharmacodynamic characterization in man. J Pharm Pharmacol. 2000 Jul;52(7):807-17.
